Skip to main content
TipRanks
Go Ultimate75% OFF

BridgeBio Oncology Therapeutics (BBOT) Technical Analysis

80 Followers

Technical Sentiment

Overall Consensus
Strong SellStrong Buy
Sell
15Bearish
2Neutral
5Bullish
Technical Analysis Consensus
Strong SellStrong Buy
Buy
3Bearish
2Neutral
5Bullish
Moving Average Consensus
Strong SellStrong Buy
Strong Sell
12Bearish
0Neutral
0Bullish

1 Day timeframe · Data as of Nov 20, 2026

  • BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.42, suggesting BridgeBio Oncology Therapeutics is a Sell.
  • BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 2.30, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $1.81, making it a Sell.
  • BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 3.45, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $1.81, making it a Sell.

BridgeBio Oncology Therapeutics (BBOT) Pivot Points

1 Day timeframe · Data as of Nov 20, 2026

BBOT pivot points
NameS3S2S1Pivot PointsR1R2R3
Classic1.601.711.781.891.962.072.14
Fibonacci1.711.781.821.891.962.002.07

BridgeBio Oncology Therapeutics (BBOT) Moving Averages

1 Day timeframe · Data as of Nov 20, 2026

BBOT moving averages
PeriodSimpleExponential
MA51.88Sell1.91Sell
MA102.09Sell2.04Sell
MA202.28Sell2.30Sell
MA503.14Sell3.45Sell
MA1005.89Sell5.05Sell
MA2007.40Sell7.04Sell
  • BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 2.04, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $1.81, making it a Sell.
  • BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 5.05, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $1.81, making it a Sell.
  • BridgeBio Oncology Therapeutics’s (BBOT) stock price is $1.81 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 3.14, creating a Sell signal.
  • BridgeBio Oncology Therapeutics’s (BBOT) stock price is $1.81 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 5.89, creating a Sell signal.
  • BridgeBio Oncology Therapeutics’s (BBOT) stock price is $1.81 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 7.40, creating a Sell signal.

BridgeBio Oncology Therapeutics (BBOT) Technical Indicators

1 Day timeframe · Data as of Nov 20, 2026

BBOT technical indicators
NameValueImplied Action
RSI (14)29.05Buy
STOCH (9,6)3.93Buy
STOCHRSI (14)3.90Buy
MACD (12,26)-0.42Sell
ADX (14)49.16Neutral
Williams %R-97.21Buy
CCI (14)-126.03Buy
ATR (14)0.25-
Ultimate Oscillator31.63Neutral
ROC-21.65Sell
  • BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 29.05, creating a Buy signal.
  • BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 49.16, creating a Neutral signal.
  • BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is -126.03, creating a Buy signal.
  • BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is -21.65, creating a Sell signal.
Technical Analysis Screener.Customize your technical analysis to fit your
unique trading strategy with a flexible screener
Try it Now!

FAQ

Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators on the 1-day timeframe as of Nov 20, 2026, BBOT is a Sell.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 29.05, which suggests BBOT is a Buy.
What is BBOT’s MACD?
BBOT’s MACD is -0.42, which suggests BBOT is a Sell.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 1.88, which suggests BBOT is a Sell.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 2.28, which suggests BBOT is a Sell.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 3.14, which suggests BBOT is a Sell.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 7.40, which suggests BBOT is a Sell.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -97.21, which suggests BBOT is a Buy.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is -126.03, which suggests BBOT is a Buy.